LANDA PROPATO: Open Payments
NPI 1033293931 · MONTGOMERYVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 21 payments from 9 companies in 2025. Trend: 2023 $277 · 2024 $322 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $131 |
| ABBVIE INC. | 4 | $75 |
| PFIZER INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Amgen Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: UBRELVY, PREVNAR 20, AIRSUPRA, TRELEGY ELLIPTA, NURTEC ODT, Kerendia, Ozempic, VRAYLAR.
Industry payments across PA — which companies pay providers there.
